IP Library › Patent Application 13657888
Patent Application
App. No. 13/657,888

METHOD OF TREATING PROSTATE CANCER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/657,888
Abstract

A therapeutic method for treating prostate cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.

Claims (7)

1 . A method for treating prostate cancer, comprising administering to a patient in need of treatment a therapeutically effective amount of a pharmaceutically acceptable salt of trans-[tetrachlorobis(1H-indazole)ruthenate(III)].

2 . The method of claim 1 , wherein the prostate cancer is a refractory prostate cancer.

3 . The method of claim 1 , wherein said pharmaceutically acceptable salt is an alkali metal salt of trans-[tetrachlorobis(1H-indazole)ruthenate(III)].

4 . The method according to claim 1 , wherein said pharmaceutically acceptable salt is sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)].

5 . The method of claim 2 , wherein said prostate cancer is refractory to a treatment comprising a taxane, or a vinca alkaloid.

6 . The method of claim 5 , wherein said prostate cancer was previously treated with a regimen comprising docetaxel.

7 . The method of claim 5 , wherein said prostate cancer was previously treated with a regimen comprising vinblastine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2013
From: NIIKI PHARMA INC.
To: NIIKI PHARMA AQUISITION CORP. 2
Reel/Frame 030740/0100 →